HIV / AIDS in the News

Scientific synergy between prophylactic and therapeutic HIV vaccines—prevention and cure - Nature

 

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2025 - KFF

 

High prices and funding cuts stall HIV prevention revolution - UN News

 

Consolidated guidance for strengthening national routine surveillance systems: updated HIV case definitions, advanced HIV disease indicators and surveillance checklist - World Health Organization (WHO)

 

WHO: Integration, innovation and community leadership key to ending HIV, hepatitis and STIs - World Health Organization (WHO)

 

Africa: U.S. Defends New HIV Funding Model As Activists Challenge PEPFAR Reforms - allAfrica.com

 

#Aids2026: Daily pill. Monthly pill. Six-monthly jab. Why choice matters - Bhekisisa

 

European Medical Journal: HIV linked to higher rates of premature ejaculation and depression - European AIDS Treatment Group

 

European Medical Journal: Kaposi sarcoma relapse reported despite HIV viral control - European AIDS Treatment Group

 

Mitchell Warren on weekly islatravir-lenacapavir for HIV treatment | AIDS 2026 - Managed Healthcare Executive

 

Health Policy Watch: African Union pushes for greater domestic spending on health amid reports of huge disruptions to HIV and TB services - European AIDS Treatment Group

 

Forty-Five Years Of HIV/AIDS And We’re Still Ignoring Black Women’s Leadership, Says New Book, Ill Erotics - Forbes

 

Countries in Latin America and the Caribbean helped build the future of HIV prevention. But will they be able to benefit from it? - Unitaid

 

Amid Row Over Exclusion, US Concedes that HIV Approach Needs to Include ‘All People at Risk’ - Health Policy Watch

 

The ‘cruel irony’ of great science, terrible politics and economics in HIV/AIDS treatment and prevention | AIDS 2026 - Managed Healthcare Executive

 

Renee Heffron, Ph.D., M.P.H., on HIV community resilience | AIDS 2026 - Managed Healthcare Executive

 

Lloyd Mulenga, M.B.Ch.B., Ph.D., on HIV prevention funding cuts | AIDS 2026 - Managed Healthcare Executive

 

Lloyd Mulenga, M.B.Ch.B., Ph.D., on Zambia's HIV funding risk | AIDS 2026 - Managed Healthcare Executive

 

Addressing the HIV Epidemic in Eastern Europe and Central Asia - The Borgen Project

 

Renee Heffron, Ph.D., M.P.H., on the case for MK-8527 | IAS 2026 - Managed Healthcare Executive

 

[AIDS 2026] [Press statement] Activists disrupt US Global AIDS Coordinator Jeff Graham at International AIDS Conference - European AIDS Treatment Group

 

Renee Heffron, Ph.D., M.P.H., on choice in HIV prevention | AIDS 2026 - Managed Healthcare Executive

 

[AIDS 2026] [Press release] Merck announces initial access plans for alimatravir, an investigational once-monthly oral HIV PrEP in Phase 3 development - European AIDS Treatment Group

 

New JIAS supplement on vaccines for the elimination of STIs - European AIDS Treatment Group

 

Gilead Targets Black Women With HIV Prevention Campaign 08/03/2026 - MediaPost

 

Opinion | Cuts to anti-AIDS foreign aid take a toll in Africa - The Washington Post

 

Thousands participating in annual HIV and AIDS bike rally from Toronto to Montreal - CTV News

 

Will Merck’s (MRK) Early Royalty-Free HIV PrEP Licensing Strategy Redefine Its Global Health Narrative - simplywall.st

 

IAS: Data revealing the impact of PEPFAR disruptions and advances in long-acting HIV prevention and treatment announced ahead of AIDS 2026 - European AIDS Treatment Group

 

Hope grows as HIV care enters a new era - The Daily Star